Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are a class of medications that have shown efficacy in lowering blood glucose levels and are commonly used in the treatment of type 2 diabetes [1]. Here, GLP1R is linked to type 2 diabetes mellitus.